Related references
Note: Only part of the references are listed.Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin
John P. Bilezikian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
Nelson B. Watts et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Higher Serum Undercarboxylated Osteocalcin and Other Bone Turnover Markers Are Associated With Reduced Diabetes Risk and Lower Estradiol Concentrations in Older Men
Bu B. Yeap et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Bisphosphonates and Glucose Homeostasis: A Population-Based, Retrospective Cohort Study
Konstantinos A. Toulis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Proportion of Undercarboxylated Osteocalcin and Serum P1NP Predict Incidence of Myocardial Infarction in Older Men
Bu B. Yeap et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Liraglutide for Type 2 diabetes and obesity: a 2015 update
Eva Winning Iepsen et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
Emily Jane Gallagher et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Diabetes and bone fracture: risk factors for old and young
Peter Vestergaard
DIABETOLOGIA (2014)
Fracture risk in diabetic elderly men: the MrOS study
Nicola Napoli et al.
DIABETOLOGIA (2014)
Suppressed Bone Turnover in Obesity: A Link to Energy Metabolism? A Case-Control Study
Heli Viljakainen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes
Ernesto Maddaloni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects
K. T. Tonks et al.
DIABETOLOGIA (2013)
Insulin-sensitive obesity in humans - a 'favorable fat' phenotype?
D. Samocha-Bonet et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes
Ippei Kanazawa et al.
BONE (2011)
Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism
Mathieu Ferron et al.
CELL (2010)
Metabolic syndrome and bone metabolism: the Camargo Cohort Study
Jose L. Hernandez et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes
Toru Yamaguchi et al.
BONE (2009)
Association between Serum Osteocalcin and Markers of Metabolic Phenotype
Anastassios G. Pittas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Relationship of Serum Osteocalcin Concentration to Insulin Secretion, Sensitivity, and Disposal with Hypocaloric Diet and Resistance Training
Jose Manuel Fernandez-Real et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Selective versus total insulin resistance: A pathogenic paradox
Michael S. Brown et al.
CELL METABOLISM (2008)
Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients A case-control study
Matteo Monami et al.
DIABETES CARE (2008)
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk
P Vestergaard et al.
DIABETOLOGIA (2005)
Diabetes and risk of fracture - The Blue Mountains Eye Study
RQ Ivers et al.
DIABETES CARE (2001)
Share Paper
